Overview

FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

Status:
Not yet recruiting

Trial end date:
2025-06-15

Target enrollment:

Participant gender:

Summary

The objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 200 women desirous of conceiving, ages ≥18 to ≤40 years (at time of consent), and known to have class 2-6 fibroids, according to the FIGO staging system.

Phase:

Phase 3

Details

Lead Sponsor:

Yale University

Collaborators:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Johns Hopkins University
University of Chicago
University of Illinois at Chicago

Treatments:

Epigallocatechin gallate